# China NMPA Drug Inspection - Wuhan Changlian Laifu Pharmaceutical Co., Ltd. - Ornidazole for injection

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/wuhan-changlian-laifu-pharmaceutical-co-ltd/4ccec3c7-88b2-49fe-9484-e5cbf7441a70
Source feed: China

> China NMPA drug inspection for Wuhan Changlian Laifu Pharmaceutical Co., Ltd. published November 11, 2021. Drug: Ornidazole for injection. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Information Bulletin on Drug Quality Sampling Inspection in Qinghai Province (Issue 2, 2021)
- Company Name: Wuhan Changlian Laifu Pharmaceutical Co., Ltd.
- Publication Date: 2021-11-11
- Drug Name: Ornidazole for injection
- Inspection Finding: Compliant

Company: https://www.globalkeysolutions.net/companies/wuhan-changlian-laifu-pharmaceutical-co-ltd/d3183d70-26a8-43f2-b441-857df78524e2